Failed pH Specification: A pH result of 2.9 was obtained at the 9 month stability test interval at 25C/60%RH. The registered specification for pH is 3.0 - 7.0
Take action
Contact the company
📍Recalling firmPfizer Inc.235 East 42nd Street · New York, NY 10017-5703
✎ GovInfoNow plain-language explainer
Pfizer Inc. is recalling Depo-Medrol (methylprednisolone acetate injectable suspension USP), 40 mg/mL, in 1 mL single-dose vials because the product failed a pH specification test. The issue was identified during a stability test at the nine-month interval, where the pH measured 2.9 against a required range of 3.0 to 7.0. Approximately 93,800 vials are affected by this nationwide recall. Read more at govinfonow.com/recall/45924-pfizer-inc-recalls-depo-medrol-methylprednisolone-acetate-injectable-suspension-usp.
“Pfizer Recalls Depo-Medrol Due to pH Failure.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45924-pfizer-inc-recalls-depo-medrol-methylprednisolone-acetate-injectable-suspension-usp. Based on FDA recall #D-1537-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1537-2014%22&limit=1).
The FDA announced on July 30, 2014, that Pfizer Inc. is recalling Depo-Medrol injectables due to a failed pH specification. The agency classified the Class III recall as voluntary.
A pH result of 2.9 was obtained at the 9-month stability test interval at 25C/60%RH, which falls outside the registered specification of 3.0 to 7.0.
Context
GovInfoNow's records show Pfizer Inc. has 71 other recalls on record since November 26, 2012. Recent Pfizer recalls include a sodium bicarbonate injection recall for lack of sterility assurance on August 4, 2025, and a Bicillin L-A injectable recall for particulate risk on July 10, 2025. Other recent recalls of similar products include a Cipla Diclofenac Gel recall for failed pH specifications (December 22, 2025), a Pfizer Dopamine HCl Inj recall for lack of sterility risk (September 4, 2026), and an Apotex Paxil CR 37.5mg Tablets recall for failed stability testing (August 13, 2026).
How to tell if you have this one
Look for Depo-Medrol (methylprednisolone acetate injectable suspension USP), 40 mg/mL, in 1 mL single-dose vials. Check for NDC numbers 0009-3073-03 or 0009-3073-23. Affected lots are H43272 and H43265 with an expiration date of 09/14.
Brand
Pfizer
Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.6 years after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1537-2014 (July 30, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1537-2014 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.